My research has focused upon drug metabolism with special, reference to carboxylesterases and variation in the genes encoding these enzymes in order to personalize drug treatments. This work has been supplemented with in silico modelling of carboxylesterases to understand the molecular basis of their hydrolysis of drugs and other substrates. My most recent research focuses upon adenosinme analogs and protides including remdesivir for treatment of covid-19.